Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...